Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases

Nature Immunology

Volumn 6, Issue 4, 2005, Pages 390-395

  Salvador, Jesus M ^a,c   Mittelstadt, Paul R ^a   Guszczynski, Tad ^b   Copeland, Terry D ^b   Yamaguchi, Hiroshi ^a   Appella, Ettore ^a   Fornace Jr , Albert J ^a,d   Ashwell, Jonathan D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE ZAP 70; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; THREONINE; TYROSINE; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN KINASE LCK; ZAP70 PROTEIN, HUMAN; ZAP70 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; B LYMPHOCYTE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; ANIMAL; CD4+ T LYMPHOCYTE; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; PEPTIDE MAPPING; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; ENZYME ACTIVATION; HUMANS; IMMUNOBLOTTING; JURKAT CELLS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MAP KINASE SIGNALING SYSTEM; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE MAPPING; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, T-CELL; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 16844367955     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1177     Document Type: Article

References (35)

1. Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature 410, 37-40 (2001).
2. Dong, C., Davis, R.J. & Flavell, R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72 (2002).
3. Rincon, M. et al. Conference highlight: do T cells care about the mitogen-activated protein kinase signalling pathways. Immunol. Cell Biol. 78, 166-175 (2000).
4. Rincon, M., Flavell, R.A. & Davis, R.A. The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses. Free Radic. Biol. Med. 28, 1328-1337 (2000).
5. Rincon, M., Flavell, R.A. & Davis, R.J. Signal transduction by MAP kinases in T lymphocytes. Oncogene 20, 2490-2497 (2001).
6. Schaeffer, H.J. & Weber, M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435-2444 (1999).
7. Davis, R.J. Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252 (2000).
8. Dong, C. et al. JNK is required for effector T-cell function but not for T-cell activation. Nature 405, 91-94 (2000).
9. Han, J. & Ulevitch, R.J. Emerging targets for anti-inflammatory therapy. Nat. Cell Biol. 1, E39-E40 (1999).
10. Rincon, M. MAP-kinase signaling pathways in T cells. Curr. Opin. Immunol. 13, 339-345 (2001).
11. Bellon, S., Fitzgibbon, M.J., Fox, T., Hsiao, H.M. & Wilson, K.P. The structure of phosphorylated p38γ is monomeric and reveals a conserved activation-loop conformation. Structure Fold. Des. 7, 1057-1065 (1999).
12. Canagarajah, B.J., Khokhlatchev, A., Cobb, M.H. & Goldsmith, E.J. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90, 859-869 (1997).
13. Ono, K. & Han, J. The p38 signal transduction pathway: activation and function. Cell. Signal. 12, 1-13 (2000).
14. Tanaka, N. et al. Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis. EMBO Rep. 3, 785-791 (2002).
15. Zhang, J. et al. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J. Immunol. 162, 3819-3829 (1999).
16. Rincon, M. et al. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17, 2817-2829 (1998).
17. Ward, S.G., Parry, R.V., Matthews, J. & O'Neill, L. A p38 MAP kinase inhibitor SB203580 inhibits CD28-dependent T cell proliferation and IL-2 production. Biochem. Soc. Trans. 25, 304S (1997).
18. Crawley, J.B. et al. T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J. Biol. Chem. 272, 15023-15027 (1997).
19. Matsuda, S., Moriguchi, T., Koyasu, S. & Nishida, E. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem. 273, 12378-12382 (1998).
20. Haeryfar, S.M. & Hoskin, D.W. Selective pharmacological inhibitors reveal differences between Thy-1- and T cell receptor-mediated signal transduction in mouse T lymphocytes. Int. Immunopharmacol. 1, 689-698 (2001).
21. Jiang, Y. et al. Structure-function studies of p38 mitogen-activated protein kinase. Loop 12 influences substrate specificity and autophosphorylation, but not upstream kinase selection. J. Biol. Chem. 272, 11096-11102 (1997).
22. Finco, T.S., Kadlecek, T., Zhang, W., Samelson, L.E. & Weiss, A. LAT is required for TCR-mediated activation of PLCγ1 and the Ras pathway. Immunity 9, 617-626 (1998).
23. Chan, A.C., Desai, D.M. & Weiss, A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12, 555-592 (1994).
24. Williams, B.L. et al. Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line. Mol. Cell. Biol. 18, 1388-1399 (1998).
25. Steinberg, M. et al. T-cell receptor-induced phosphorylation of the ζ chain is efficiently promoted by ZAP-70 but not Syk. Blood 104, 760-767 (2004).
26. Salojin, K.V., Zhang, J. & Delovitch, T.L. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway. J. Immunol. 163, 844-853 (1999).
27. Yu, H., Leitenberg, D., Li, B. & Flavell, R.A. Deficiency of small GTPase Rac2 affects T cell activation. J. Exp. Med. 194, 915-926 (2001).
28. Salvador, J.M., Mittelstadt, P.R., Belova, G.I., Fornace, A.J., Jr & Ashwell, J.D. The autoimmune suppressor Gadd45α inhibits the T cell alternative p38 activation pathway. Nat. Immunol. (27 February 2005) doi: 10.1038/ni1176.
29. Chi, H., Lu, B., Takekawa, M., Davis, R.J. & Flavell, R.A. GADD45β/GADD45γ and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNγ production in T cells. EMBO J. 23, 1576-1586 (2004).
30. Wilson, K.P. et al. Crystal structure of p38 mitogen-activated protein kinase. J. Biol. Chem. 271, 27696-27700 (1996).
31. Weiss, A. & Littman, D.R. Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274 (1994).
32. Bell, M. & Engelberg, D. Phosphorylation of Tyr-176 of the yeast MAPK Hog1/p38 is not vital for Hog1 biological activity. J. Biol. Chem. 278, 14603-14606 (2003).
33. Ge, B. et al. MAPKK-independent activation of p38α mediated by TAB1-dependent autophosphorylation of p38α. Science 295, 1291-1294 (2002).
34. D'Oro, U., Sakaguchi, K., Appella, E. & Ashwell, J.D. Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol. Cell. Biol. 16, 4996-5003 (1996).
35. Salvador, J.M. et al. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16, 499-508 (2002).